J&J Ultram Titration Relabeling Should Not Block Generics, Apotex Argues
Executive Summary
Apotex' citizen petition requesting approval of generic Ultram argues that Johnson & Johnson did not make labeling changes for safety or efficacy reasons
You may also be interested in...
36Ultram Generics Will Reference 50 mg, But Not 25 Mg, Titration Schedule
FDA is approving Ultram (tramadol) generics with labeling that includes the 50 mg titration regimen, but not the protected 25 mg titration schedule
36Ultram Generics Will Reference 50 mg, But Not 25 Mg, Titration Schedule
FDA is approving Ultram (tramadol) generics with labeling that includes the 50 mg titration regimen, but not the protected 25 mg titration schedule
Ultram Generic Approval For Acute Pain Would Avoid Protected Label – Teva
Teva is seeking approval for a generic version of Johnson & Johnson's Ultram (tramadol) only for acute pain in order to circumvent the brand's patent-protected titration schedule